Achieve Life Sciences (ACHV) Cash from Investing Activities (QoQ) (2010 - 2026)
Achieve Life Sciences (ACHV) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,913.54% |
| Dec 31, 2025 |
105.60% |
| Sep 30, 2025 |
-288.78% |
| Jun 30, 2025 |
-40.96% |
| Mar 31, 2025 |
-3.11% |
| Dec 31, 2024 |
-11.71% |
| Sep 30, 2020 |
75.00% |
| Jun 30, 2020 |
-500.00% |
| Mar 31, 2020 |
-100.00% |
| Jun 30, 2019 |
-12.75% |
| Mar 31, 2019 |
172.53% |
| Dec 31, 2018 |
-166.83% |
| Sep 30, 2018 |
-3,761.11% |
| Jun 30, 2018 |
-460.00% |
| Mar 31, 2018 |
-96.32% |
| Dec 31, 2017 |
-87.33% |
| Sep 30, 2017 |
182.50% |
| Jun 30, 2017 |
-91.97% |
| Mar 31, 2017 |
-9.07% |
| Dec 31, 2016 |
22.78% |
